BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28928392)

  • 1. Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis.
    Lee CH; Bae SJ; Kim M
    Sci Rep; 2017 Sep; 7(1):11889. PubMed ID: 28928392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function.
    Meloni L; Verstrepen L; Kreike M; Staal J; Driege Y; Afonina IS; Beyaert R
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30513612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
    Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
    J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
    Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
    Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
    Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
    J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
    Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
    J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency.
    Monajemi M; Fisk S; Pang YCF; Leung J; Menzies SC; Ben-Othman R; Cai B; Kollmann TR; Rozmus J; Sly LM
    J Leukoc Biol; 2019 Oct; 106(4):863-877. PubMed ID: 31313375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis.
    Gilis E; Gaublomme D; Staal J; Venken K; Dhaenens M; Lambrecht S; Coudenys J; Decruy T; Schryvers N; Driege Y; Dumas E; Demeyer A; De Muynck A; van Hengel J; Van Hoorebeke L; Deforce D; Beyaert R; Elewaut D
    Arthritis Rheumatol; 2019 Dec; 71(12):2005-2015. PubMed ID: 31259485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease.
    Asaba KN; Adachi Y; Tokumaru K; Watanabe A; Goto Y; Aoki T
    Bioorg Med Chem Lett; 2021 Jun; 41():127996. PubMed ID: 33775836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase.
    Jia Y; Miao Y; Yue M; Shu M; Wei Z; Dai Y
    FASEB J; 2018 Jun; 32(6):3398-3410. PubMed ID: 29401630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT1 regulates Th2 and Th17 differentiation
    Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
    Front Immunol; 2022; 13():913830. PubMed ID: 35967391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
    Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
    J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.
    Cheng CP; Huang HS; Hsu YC; Sheu MJ; Chang DM
    J Clin Immunol; 2012 Aug; 32(4):762-77. PubMed ID: 22396044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis.
    Wang Y; Liu Z; Zhang M; Yu B; Ai F
    Front Microbiol; 2023; 14():1117285. PubMed ID: 36960276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
    Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
    Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MALT1 Suppresses the Malignant Progression of Colorectal Cancer
    Qian R; Niu X; Wang Y; Guo Z; Deng X; Ding Z; Zhou M; Deng H
    Front Cell Dev Biol; 2022; 10():845048. PubMed ID: 35309901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.
    Wittner L; Wagener L; Wiese JJ; Stolzer I; Krug SM; Naschberger E; Jackstadt R; Beyaert R; Atreya R; Kühl AA; Sturm G; Gonzalez-Acera M; Patankar JV; Becker C; Siegmund B; Trajanoski Z; Winner B; Neurath MF; Schumann M; Günther C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation.
    Wang R; Zhang H; Xu J; Zhang N; Pan T; Zhong X; Zhang H; Yin L; Yao Y; Wu Q; Li Z; Liu X; Xu K; Niu M
    Front Oncol; 2020; 10():558339. PubMed ID: 33072583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.
    Li YJ; Kukita A; Watanabe T; Takano T; Qu P; Sanematsu K; Ninomiya Y; Kukita T
    Lab Invest; 2012 Dec; 92(12):1777-87. PubMed ID: 23044922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.